scholarly journals Renal Lymphoma Mimicking a Retroperitoneal Hematoma

Cureus ◽  
2021 ◽  
Author(s):  
Ana Primitivo ◽  
Pedro M Sousa ◽  
Ana F Ferreira
Keyword(s):  
Retroperitoneal Hematoma ◽  
Renal Lymphoma

Perforation of inferior vena cava during filter placement

VASA ◽  
2011 ◽  
Vol 40 (2) ◽  
pp. 157-162 ◽  
Author(s):  
Piecuch ◽  
Wiewiora ◽  
Nowowiejska-Wiewiora ◽  
Szkodzinski ◽  
Polonski
Keyword(s):  
Pulmonary Embolism ◽  
Inferior Vena Cava ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Inferior Vena ◽  
Vena Cava ◽  
Retroperitoneal Hematoma ◽  
Ivc Filter ◽  
Filter Placement ◽  
Therapeutic Method

The placement of an inferior vena cava (IVC) filter is a therapeutic method for selected patients with deep venous thrombosis and pulmonary embolism. However, insertion and placement of the filter may be associated with certain complications. For instance, retroperitoneal hematoma resulting from perforation of the wall by the filter is such a very rare but serious complication. We report the case of a 64-year-old woman with perforation of the IVC wall and consecutive hematoma caused by the filter who was treated surgically.

CT of Blunt Renal Injury; Correation of Renal Injury and Retroperitoneal Hematoma

1994 ◽  
Vol 30 (6) ◽  
pp. 1109
Author(s):  
Sung Tae Kim ◽  
On Koo Cho ◽  
Hyun Chul Rhim ◽  
Byung Hee Koh ◽  
Moon Hwan Choi ◽  
...  
Keyword(s):  
Renal Injury ◽  
Retroperitoneal Hematoma

MR Finding of Primary Renal Lymphoma: A Case Report

1995 ◽  
Vol 33 (3) ◽  
pp. 411
Author(s):  
Sun Wha Lee ◽  
Hye Young Choi ◽  
Seung Yon Baek ◽  
Eun Joo Ahn
Keyword(s):  
Case Report ◽  
Renal Lymphoma

Pelvic Fractures With Associated Retroperitoneal Hematoma: Time Until Angioembolization and Results

2019 ◽  
Vol 97 (5) ◽  
pp. 261-267
Author(s):  
Patricia Ciriano Hernández ◽  
Ana Moreno Hidalgo ◽  
Irene Grao Torrente ◽  
Cristina Ruiz Moreno ◽  
Leticia Seisdedos Rodrigez ◽  
...  
Keyword(s):  
Pelvic Fractures ◽  
Retroperitoneal Hematoma

scholarly journals Spontaneous Retroperitoneal Hematoma in COVID-19 Severe Pneumonia–Dual-phase Multidetector Computed Tomography (MDCT) Angiogram and Role of Radiologist

2021 ◽  
Author(s):  
Vikash Kumar Gupta ◽  
Buthaina Mohammad Alkandari ◽  
Wasif Mohammed ◽  
Mohsen Ahmed Abdelmohsen ◽  
Mohammad Gaber Abdullah Mohammad
Keyword(s):  
Significant Risk ◽  
Severe Pneumonia ◽  
Retroperitoneal Hematoma ◽  
Low Molecular Weight ◽  
Rt Pcr ◽  
Prophylactic Dose ◽  
Therapeutic Anticoagulation ◽  
Coagulation Tests ◽  
Polymerase Chain

AbstractStudies available in the literature have shown alterations in blood coagulation tests in severe cases of COVID-19 pneumonia, with a significant risk of venous thromboembolism (VTE). Since microvascular thrombosis is a well-known fact in COVID-19 disease, requiring therapeutic anticoagulation, low-molecular weight heparin (LMWH) in prophylactic dose is a part of the clinical management of hospitalized COVID-19 patients. In this scenario, we describe three cases of abdominal spontaneous retroperitoneal hematoma (SRH) in hospitalized reverse transcriptase-polymerase chain reaction (RT-PCR)-confirmed COVID-19 patients.

Incidence and treatment of feline renal lymphoma: 27 cases

2021 ◽  
pp. 1098612X2098436
Author(s):  
Ashlyn G Williams ◽  
Ann E Hohenhaus ◽  
Kenneth E Lamb
Keyword(s):  
Median Survival ◽  
Clinical Stage ◽  
Large Population ◽  
Clinical Signs ◽  
Treatment Protocol ◽  
Central Nervous System Involvement ◽  
Data Set ◽  
Hematopoietic Malignancy ◽  
Renal Lymphoma ◽  
Multicentric Lymphoma

Objectives Lymphoma is the most common feline hematopoietic malignancy. Incidence of renal lymphoma has not been reported as a subset of a large population of feline lymphoma cases. Previous studies have reported renal lymphoma as both a singular entity as well as a component of multicentric disease. The clinical presentation, diagnostic evaluation, therapy and outcomes related to renal lymphoma have not been reported since Mooney et al in 1987. This retrospective study aimed to describe the incidence of renal lymphoma, clinical signs, treatment and survival. Methods Using a database of cats diagnosed with lymphoma between January 2008 and October 2017, cats with renal lymphoma were selected for further analysis. Cases were retrospectively staged according to Mooney et al (1987) and Gabor et al (1998). Data collected included age, clinical signs, clinicopathologic data, diagnostic imaging findings, lymphoma diagnostic method(s), treatment protocol(s) and survival time. Analyses comparing median survival based on therapy administered, renal lymphoma vs multicentric lymphoma, central nervous system involvement, presence of azotemia, anemia and International Renal Interest Society (IRIS) stage at diagnosis were performed. Results From a population of 740 cats with lymphoma, 27 cats had renal lymphoma (incidence, 3.6%), and 14 of those cats had multicentric lymphoma. Fewer stage IV and V cases were identified in this data set compared with Mooney et al; however, not all cats were completely staged. Median survival (range) for cats receiving corticosteroids alone compared with those receiving an L-CHOP (L-asparaginase, vincristine, cyclophosphamide, doxorubicin, prednisolone)-based protocol was 50 days (20–1027 days) in the corticosteroid group and 203 days (44–2364 days) for the L-CHOP group ( P = 0.753) for cats that died secondary to lymphoma. Conclusions and relevance Neither clinical stage nor other factors were predictive of survival. Prospective studies are required to determine the optimal chemotherapy protocol.

scholarly journals A Clinical and Experimental Study of Acquired Inhibitors to Factor VIII

Blood ◽  
1965 ◽  
Vol 26 (6) ◽  
pp. 805-818 ◽  
Author(s):  
HAROLD R. ROBERTS ◽  
MARGARET B. SCALES ◽  
JOHN T. MADISON ◽  
WILLIAM P. WEBSTER ◽  
GEORGE D. PENICK
Keyword(s):  
Experimental Study ◽  
Factor Viii ◽  
Mode Of Action ◽  
Exchange Transfusion ◽  
Hemophilia A ◽  
Retroperitoneal Hematoma ◽  
Factor Viii Inhibitor ◽  
Viii Inhibitor ◽  
Potent Factor

Abstract Factor VIII inhibitors which developed in four patients with hemophilia A are described. These inhibitors are apparently specific for Factor VIII and are capable of inducing a transient hemophilic state when injected into dogs. The genesis, properties, and mode of action of these inhibitors can be explained on an immunologic basis and it seems most likely that they represent an antibody to Factor VIII. One hemophilia A patient, with retroperitoneal hematoma and a potent Factor VIII inhibitor, was successfully treated by an exchange transfusion followed by administration of purified porcine Factor VIII.

Imaging of Primary and Secondary Renal Lymphoma

2013 ◽  
Vol 201 (5) ◽  
pp. W712-W719 ◽  
Author(s):  
Dhakshinamoorthy Ganeshan ◽  
Revathy Iyer ◽  
Catherine Devine ◽  
Priya Bhosale ◽  
Erik Paulson
Keyword(s):  
Renal Lymphoma
Sign in / Sign up

Export Citation Format

Share Document